RICHTER'S TRANSFORMATION

Clinical trials for RICHTER'S TRANSFORMATION explained in plain language.

Never miss a new study

Get alerted when new RICHTER'S TRANSFORMATION trials appear

Sign up with your email to follow new studies for RICHTER'S TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

New pill tested as potential lifeline for Tough-to-Treat blood cancers

Disease control Ongoing

This study is testing a new oral medication called nemtabrutinib for people with advanced B-cell blood cancers that have come back or stopped responding to other treatments. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. It is for a…

Matched conditions: RICHTER'S TRANSFORMATION

Phase: PHASE1, PHASE2 • Sponsor: ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

RICHTER'S TRANSFORMATION

Get alerted when new RICHTER'S TRANSFORMATION trials appear

New pill tested as potential lifeline for Tough-to-Treat blood cancers